Education
About Us
Working with TipRanks
Follow Us
Kraig Biocraft Laboratories (KBLB)
:KBLB
KBLB Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $0.16
Previous CloseN/A
Volume517.16K
Average Volume (3M)580.15K
Market Cap
$90.95M
Enterprise ValueN/A
Total Cash (Recent Filing)$13.70K
Total Debt (Recent Filing)$322.00K
Price to Earnings (P/E)―
Beta1.48
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding1,039,455,700
10 Day Avg. Volume765,724
30 Day Avg. Volume580,153
Standard Deviation0.24
R-Squared0.02
Alpha0.00342
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-69.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Kraig Biocraft Laboratories News
PremiumCompany Announcements
Kraig Biocraft Secures $10M for Spider Silk Growth---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
KBLB FAQ
What was Kraig Biocraft Laboratories’s price range in the past 12 months?
Kraig Biocraft Laboratories lowest stock price was $0.06 and its highest was $0.16 in the past 12 months.
What is Kraig Biocraft Laboratories’s market cap?
Kraig Biocraft Laboratories’s market cap is $90.95M.
When is Kraig Biocraft Laboratories’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Kraig Biocraft Laboratories’s earnings last quarter?
Kraig Biocraft Laboratories released its earnings results on May 12, 2023. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.
Is Kraig Biocraft Laboratories overvalued?
According to Wall Street analysts Kraig Biocraft Laboratories’s price is currently Overvalued.
Does Kraig Biocraft Laboratories pay dividends?
Kraig Biocraft Laboratories does not currently pay dividends.
What is Kraig Biocraft Laboratories’s EPS estimate?
Kraig Biocraft Laboratories’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kraig Biocraft Laboratories have?
Kraig Biocraft Laboratories has 1,039,455,700 shares outstanding.
What happened to Kraig Biocraft Laboratories’s price movement after its last earnings report?
Kraig Biocraft Laboratories reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Kraig Biocraft Laboratories?
Currently, no hedge funds are holding shares in KBLB
---
Kraig Biocraft Laboratories Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Hedge Fund Trend
Decreased
By 70.0K Shares
Last Quarter.
Last Quarter.
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-11.22%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-44.13%
Trailing 12-Months
Company Description
Kraig Biocraft Laboratories
Kraig Biocraft Laboratories, Inc. operates as a biotechnology company, which focuses on the development and commercialization of spider silk. It specializes in the global textiles industry, genetic research and product development. The company was founded by Kim K. Thompson on April 25, 2006 and is headquartered in Ann Arbor, MI.
---
Technical Analysis
---